Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced ...

Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in for beginners. In a report released on August ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

Boston Scientific has updated the instructions for use for products deployed in the implantation of its Watchman heart device ...

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and ...

Boston Scientific has launched Endura Weight Loss Solutions, alongside survey findings showing that many U.S. women are ...

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston Scientific told customers that its Endotak Reliance defibrillation leads with ...

Marlborough, Mass.-based Boston Scientific’s new Endura Weight Loss Solutions offers minimally invasive procedures for patients who want alternatives to diet, medication and bariatric surgery.

Marlborough, Mass.-based Boston Scientific has launched Endura Weight Loss Solutions, a new line of minimally invasive endobariatric procedures such as endoscopic sleeve gastroplasty and Orbera ...

Boston Sci is offering up 14,500 South Korean won (about $11 U.S.) per M.I.Tech share, with the total asking price coming out to 291.2 billion won, or about $230 million.

Boston Scientific’s revenues rose from $18.4 billion in 2019 to $20.2 billion in 2022, driven by an uptick in total procedures after a decline during the pandemic period.